HNRNPA2B1 and cancer: For example, the increased expression of HNRNPA2B1 leads to tumor suppression in multiple cancers, including pancreatic ductal adenocarcinoma, ovarian cancer, hepatocellular carcinoma, lung cancer, melanoma, glioblastoma, and prostate cancer [9–15].